Dongiovanni et al, 201028a investigated the PPARG (Pro12Ala) and PPARA (Leu162Val) variants in a biopsy-proven NAFLD cohort of 202 Italian patients, compared with 346 healthy controls. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.